Libourne, France- August 2013.

Ceva is pleased to announce the launch of www.vectormune.com
The site provides quick and easy access to essential information about Vectormune® vaccines, which are today the broadest and most complete range of vector vaccines available.

The site includes product videos, scientific publications, and a newsroom.

The special feature: “Educational Symposia” gives easy and free access to the web seminars and presentations from the last two major scientific meetings on new technology vaccines, the most recent of which was held in Miami, during March 2013.

The Vectormune site is part of Ceva’s ongoing efforts to enhance the quality and availability of information available to poultry professionals, in order that the real benefits that these innovative vaccines offer is translated into improved flock health and production

To see the new website, please visit: www.vectormune.com

About Vectormune ®
Vectormune ® is the broadest range of vector technology vaccines for poultry. These vector vaccines express the major immunogenic proteins to block viruses, giving higher levels of protection that last for the life of the bird, regardless of the level of maternal immunity. Vectormune® vaccines use either Marek’s Disease virus or Fowl Pox viruses to express key protective antigens against Newcastle Disease (Vectormune ® ND), Avian Influenza (Vectormune ® AI), Laryngothacheitis (Vectormune® FP LT and Vectormune® LT) and Mycoplasma (Vectormune® FP MG).

Other details, information, on request from:
Martin Mitchell
Group Communications Director
Email: martin.mitchell@ceva.com

Sylvain Comte
Corporate Marketing Director-Poultry
 Email: sylvain.comte@ceva.com